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Abstract. Synaptophysin is a major transmembrane 
glycoprotein of a type of small vesicle with an 
electron-translucent content (SET vesicles), including 
the *50-nm presynaptic vesicles in neuronal cells, and 
of similar,  somewhat larger (<m90 rim) vesicles 
(SLMV) in neuroendocrine (NE) cells. When certain 
epithelial non-NE cells, such as human hepatocellnlar 
carcinoma PLC cells, were cDNA transfected to syn- 
thesize synaptophysin, the new molecules appeared in 
specific SET vesicles. As this was in contrast to other 
reports that only NE cells were able to sort synap- 
tophysin away from other plasma membrane proteins 
into presynaptic- or SLMV-type vesicles, we have fur- 
ther characterized the vesicles containing  synaptophy- 
sin in transfected PLC cells. Using fractionation and 
immunoisolation techniques,  we have separated differ- 
ent kinds of vesicles, and we have identified a distinct 
type of synaptophysin-rich,  small (30-90-rim) vesicle 
that contains little,  if any, protein of the constitutive 
secretory pathway marker hepatitis B surface antigen, 
of the fluid phase endocytosis marker HRP, and of the 
plasma membrane recycling endosomal marker trans- 
fen'in receptor.  In addition,  we have found variously 
sized vesicles that contained both synaptophysin and 
transferrin  receptor.  A  corresponding result was also 
obtained by direct visualization,  using double-label 
immunofluorescence microscopy for the endocytotic 
markers and synaptophysin in confocal laser scan mi- 
croscopy and in double-immunogold label electron mi- 
croscopy. We conclude that diverse non-NE cells of 
epithelial nature are able to enrich the "foreign" mole- 
cule synaptophysin in a category of SET vesicles that 
are morphologically indistinguishable  from SLMV of 
NE cells, including one type of vesicle in which syn- 
aptophysin is sorted away from endosomal marker pro- 
teins.  Possible mechanisms of this sorting are dis- 
cussed. 
I 
NTERCELLULAR  fast signal transduction  is facilitated by 
exocytosis of neurotransmitter-containing,  small  (di- 
ameter =  30-90 nm) electron translucent  (SET) I vesi- 
cles, of which the '~50 nm presynaptic  vesicles  (PSV)  of 
neurons are the prototype. Despite the identification of an in- 
creasing number of molecules constituting  the membrane of 
such  vesicles  (for  review  see reference  43),  and  despite 
numerous observations of vesicle exocytosis  and recycling by 
endocytosis (e.g.,  14, 21-23,  31,  32, 46, 48), the mecha- 
nisms of the formation  of these organelles  in the living cell 
are still unknown.  Therefore,  recent observations of com- 
positionally  similar,  only somewhat larger  (~<90 nm)  and 
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more pleiomorphic SET vesicles  in neuroendocrine  (NE) 
cells, which are now collectively referred to as "synaptic-like 
microvesicles" (SLMV), have initiated a series of studies of 
SET vesicle formation  and turnover  (e.g., 2-5, 28, 33, 37, 
38, 45). 
Particular attention has been paid to the synthesis and sort- 
ing of synaptophysin,  the major transmembrane glycopro- 
tein of PSV and of SLMV in different kinds of NE cells (e.g., 
9, 26, 33, 39, 52, 54; for a recent review see 45). The highly 
conserved synaptophysin  gene (25, 42) encodes a polypep- 
tide of mol wt 33,312 (in rat) with four transmembrane do- 
mains that is N-glycosylated in the first intravesicular  loop 
domain (26), can be phosphorylated in specific ways (35; for 
review see also reference 43), is sulfated  on carbohydrate 
moieties (38),  and is stabilized by intramolecular  disulfide 
bonds (20). It forms homooligomers,  which confer voltage- 
gated channel  conductance after integration  into lipid  bi- 
layers (20, 44). The specific forms of N-glycosylation  and 
sulfation are commonly taken as an indication of its passage 
through  the Golgi apparatus and  the trans-Golgi network 
(38, 52), and the glycoprotein  has indeed been detected by 
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and NE cells  (37,  46; for support by other  methods see II). 
It  has also  been proposed that  upon vesicle  exocytosis,  syn- 
aptophysin is transiently  integrated  into the plasma mem- 
brane, whereupon it  is quickly recycled in the endocytotic 
compartment, defined by its ability  to take  up fluid-phase 
markers such as HRP and to  coaccumulate with various  re- 
cycling receptors such as transferrin  receptor (TFR) and 
LDL receptor  (e.g.,  2, 19, 26, 28, 38, 45, 47; for  a contrast- 
ing statement see reference 3). Unknown  NE  cell type- 
specific sorting  mechanisms have then been postulated  by 
several  authors  to effect  the subsequent separation  of  synap- 
tophysin from these  receptors  and other proteins,  resulting 
in its concentrating in SET vesicles throughout the cyto- 
plasm and their  possible  exocytotic  rereleasc  to the  cell  sur- 
face (2, 21-23, 28, 38, 43). 
By forced overexpression of synaptophysin in cultured 
non-NE  cells transfectcd with  synaptophysin  gene con- 
structs,  it  was shown that  the  "foreign"  glycoprotein  accumu- 
lated  in  certain  small  vesicles  (cf.  19, 26, 28). However, the 
mode of formation and the nature of these vesicles  has re- 
mained a matter of controversy. We have reported that  in 
such transfected  cells,  a considerable proportion of synap- 
topbysin is  sorted  away from other  membrane proteins,  and 
it  is  enriched in SLMV, either  alone or in combination with 
other  minor components (26).  Other authors  have concluded 
that  specific  sorting  into  PSV or SLMV  is  exclusive  to NE 
cells,  in which synaptophysin is  sorted  away from other  en- 
dosomal membrane proteins  (2, 3, 6, 21-23, 28). Since the 
latter  concept predicts  for  all  non-NE cells  a  complete codis- 
tribution  of  synaptophysin with endocytosed  surface  recep- 
tors,  as well  as the inability  of  sorting  this  glycoprotcin  into 
SLMV,  wc examined the intraccllular  distribution  of these 
molecules  in several  transfected non-NE cell  lines,  using 
biochemical and immunolocalization methods. 
Materials and Methods 
Cell Culture 
The  following human  cell  lines  were  used:  hepatocellular  carcinoma- 
derived PLC cell sublines PLC (ATCC CRL 8024) and PLC-SS4 (26), as 
well as SK-Hep-1 cells (ATCC HTB 52),  and vulvar carcinoma-derived 
A-431 cells (clone E3; ATCC CRL 1555). For metabolic labeling, cells 
were grown in a culture dish (10 cm in diameter) to confluency, and they 
were then incubated either overnight (16 h) in growth medium with a re- 
duced methionine content to which 150 ~,Ci [3SS]methionine  (Amersbam 
International, Amersham, Bucks, U.K.) had been added, or for 1 h in Ex- 
Cell 40 medium (Sera-Lab Ltd., Sussex, U.K.). In some cases, cells were 
treated with 5 ~g/ml brefeldin A (Sigma Lrmnunochemicals,  St. Louis, MO) 
for ~3 h and/or 20/~g/mi cycloheximide (Sigma) for ~8 h. 
For comparison,  NE cells of line PC12 were grown as described (9). 
DNA Transfection 
DNA transfection was done either by the calcium phosphate precipitation 
method (cf. 26) or by lipofection (7). In brief, plasmid DNA was purified 
by two cycles of cesium chloride centrifugation, and 25 ~tg DNA were dis- 
solved in 450 ~1 H20. 50/tl of a 2.5-M CaCI2 solution was added, and the 
whole mixture was dropwise pipeted into 500 ld 2x BES buffer (lx BES 
buffer is  140 mM NaCI, 0.75 M Na2HPO4, 50 mM N,N-bis-[2-hydroxy- 
ethyl]-2-aminoethanesulfonic acid  (BES) adjusted to pH 7.05 with  1 N 
KOH) while vortexing. After incubation at room temperature for 20 win, 
the solution was added to a culture at low density (20-40 % confluent) in 
a  10-cm culture dish. The cells were incubated with the precipitate over- 
night (16 h) under reduced CO2 concentration (3%).  ARer three washes 
with DME, cells were treated with 15% glycerol in Ix BES for 3 rain and 
three washes with DME, followed by the addition of  regular growth medium 
supplemented with penicillin-streptomycin (loo U/mi; Gibco, Karlsruhe, 
FRG). For selection of stably transfected cell clones, puromycin (Sigma) 
was added to a final concentration of 4 ~g/ml,  and single colonies were 
picked with a pipet (Gilson Medical Electronic Instruments,  Middleton, 
WI) "~2  wk later.  Expression  was  determined  by  immunofluorescence  mi- 
croscopy  and Northern  blotting.  For  increased  expression  of  transgenes, 
transiently  and  stably  transfeetad  cells  were  sometimes  treated  with  5  mM 
sodium butyrate  (Sigma) for 24 h (cf. 26). 
For  lipofection,  20/~g  CsCl-purified  plasmid  DNA was  dissolved  in  IOO 
#l H20, and 80 /~g lipofectin  reagent  (BILL,  Gaithershurg,  MD) was 
diluted in a separate tube to 100/tl with H20. Both solutions were mixed 
gently in a polystyrene tube and incubated at room temperature for 15 min. 
Cells grown in 10-cm culture dishes to ,v50%  confluency were washed 
three times with serum-free medium. 10 ml serum-free medium was added, 
and  the lipofectin reagent-DNA  complexes were dropwise added while 
swirling the plates.  ARer  16 h incubation,  regular growth medium was 
added,  and the cells were propagated and selected as described above. 
To optimize the level of synaptophysin expression, several promoters in 
various plasmid constructs were tested.  Best results were obtained with 
plasmid  clone  pSR  I°,  which  contains  the •1  kbp  KpnI/BamHI  synap- 
tophysin encoding insert of clone pSR  s (26) in the eukaryotic expression 
vector pBEHpaclS. This vector contains two separate SV-40 promoter/en- 
hancer regions that drive the expression of  any inserted foreign gene, as well 
as of the puromycin resistance gene (17). 
Endocytosis of TFR, TF, and HRP 
For TFR endocytosis, cells were washed three times with serum-free DME 
and were then incubated in serum-free DME for 1 h at 37°C. After several 
washes with ice-cold DME, cells  were incubated at 4°C in serum-free DME 
containing  TFR antibody 133/25 (Boehringer MannbeLm GmbH, Mann- 
helm, FRG) at a concentration of 1-10 ~g/ml for 30 rain. Addition of  diferric 
TF (from Collaborative Research, Inc., Bedford, MA, or Bayer Diagnostic 
GmbH,  Miinchen, FRG) did not significantly alter the results (of. 1, 50), 
and it was therefore omitted in the later experiments. In some experiments, 
15-nm gold  particles  coupled  to  sheep  anti-mouse IgG  or 35S-labeled 
sheep anti-mouse IgG  (Amersham  International)  were  added  in  sub- 
stoichiometric amounts at the same time. The resulting differences in half- 
life and cell surface expression of  the TFR are not of  relevance for this study 
since receptor recycling is only insignificantly altered (see reference 51). 
Accordingly, light microscopic controls did not show any differences in TFR 
distribution.  After the adsorption at 4°C, FCS was added (5%), and cells 
were incubated for various time intervals of g 2 h (in most cases, a 60-min 
incubation period was used, which is considerably longer than the reported 
time for saturation of intracellular TFR-containing organelles in other cell 
systems (e.g.,  13,  18). 
For transferrin (TF) endocytosis, cells were washed and preincubated as 
described above. Thereafter, cells were incubated with diferric TF at a con- 
centration below receptor saturation (15/tg/ml)  for 30 min at 37°C. Cells 
were washed extensively with PBS before further processing. 
For endocytosis of HRP (type VI, Sigma), cells were incubated with 
HRP at a concentration of 10 mg/ml for various time intervals ranging from 
5 rain to 2 h (cf. 26). In biochemical analyses, peroxidase activity was deter- 
mined by incubation of 0.2 ml of  cellular fractions (usually obtained by su- 
crose density gradient centrifugation) with 0.8 ml of  a freshly prepared assay 
solution containing 0.1 M sodiumcitrate (pH 5.5), 0.125% Triton X-t00, 
0.804 mM o-dianisidine, and 0.103 mM H202. Adsorption was measured 
at 450 ran exactly 30 min after mixing, and was compared to activities of 
known concentrations of HRP (0.05 ng, 0.1 ng, 0.2 ng). 
Antibodies 
Synaptophysin mAb SY38 (52) was used after purification by HPLC. Mu- 
fine mAbs B3/25 (Boehringer Mannheim) and OKT9 (ATCC CRL8021; 
purified antibody was kindly provided by Dr. Rudolf Tanber (Free Univer- 
sity of Berlin,  FRG; cf. reference 34) against the human TFR were used 
at a dilution of 1:50 or 1:200, respectively, for immunofluorescence micros- 
copy. Antibodies  recognizing  specifically human  "IT were  from rabbits 
(Janssen Biochimica, Beerse, Belgium) or goats (Bio-Science Products AG, 
Emmenbriicke, Switzerland), and sheep antibodies against the hepatitis B 
virus  surface antigen were obtained  from Dako Diagnostika (Hamburg, 
FRG). 
Polyclonal synaptophysin antibodies from rabbits (cf 9, 26) and guinea 
pigs were affinity purified on fusion proteins that had been produced  in 
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carboxyterminus of synaptophysin was excised from clone pSR  5 (26) and 
inserted into the NruI site of the E. coli expression vector pAX5  + (Medac, 
Hamburg, FRG). The plasmid was grown in E. coil (TG1) cells of a dense 
overnight  culture  that  was  diluted  1:10 (0.5  liter),  and  was  further 
propagated at 250C  to an OD~0o of 0.2. Fusion protein synthesis was in- 
duced by addition of isopropyl-thiogalaetoside (final concentration  =  1 
/~M) and a temperature shift to 370C. After 2 h, calls were pelleted (5,000 g; 
10 rain at 4°C) and then resnspended in 20 ml ice-cold solution (0.5  M 
NaC1, 20 mM Tris-HCl, pH 7.5), 2 mM EDTA, 10 mM ~-mercaptoethanol, 
1 mM PMSF) containing 25 td aprotinin (Sigma). Cells were lysed by re- 
peated sonication, and the lysate was centrifuged for 1 h at 100,000  g and 
4°C. The NaC1 concentration of the resulting supernatant was adjusted to 
1.6 M, and the solution was loaded onto a p-aminophenyl-/~-t)-thiogalac- 
toside column (MoBiTec  GmbH, Gtttingen, FRG), prcequilibrated with a 
buffer consisting of 20  mM Tris-HC1  (pH 7.4),  10 mM MgCI2,  1.6 M 
NaC1,  and 10 mM ~-mereaptoethanol. The column was then extensively 
washed with this equilibration buffer, and bound polypeptides were eluted 
with 0.1 M di-sodium-tetraborate (pH 10.3) containing 10 mM/3-mercap- 
toethanol. The pH of the eluate was neutralized by addition of HC1. 
For affinity purification of antibodies, the purified fusion proteins were 
bound to nitrocellulose strips (1 mg/cm2). Filters were then blocked with 
1% goat serum in PBS at 40C overnight or at room temperature for 1 h. 
All tubes used for subsequent handling were pre-adsorbed in the same man- 
ner for ~30 rain at room temperature. Blocked nitrocellulose strips were 
incubated with antiserum (diluted in PBS) for at least 1 h. The supernatant 
was saved and could be used for another round of  adsorption if it still showed 
reactivity. Filters were washed three times with PBS, and bound antibody 
was released by incubation in 3 M potassium thiocyanate for 5 rain. The 
solution was then diluted to <1 M by PBS, and the supernatant was concen- 
trated  in a  microconcentrator (Centricon 30;  Amicon,  Danvers,  MA). 
Filters were used for several cycles of affinity purification. 
Immunofluorescence and Immunoelectron Microscopy 
FOr immunofluorescence microscopy, cells were grown on glass coverslips 
that in many experiments had been pretreated with 0.1%  (wt/vol) poly-L- 
lysine solution (Sigma). The coverslips were thoroughly rinsed with 37°C 
warm PBS (pH 7.4),  fixed for 5 rain in methanol (at -200C), treated with 
acetone for 30 s at -20°C, and air dried. After rehydration in PBS the slides 
were incubated with the primary antibodies for 30 rain in a wet chamber, 
followed by  three  5-min  washes  with  PBS  and  incubation  with  Texas 
red-coupled or fluorescein-isothiocyanate-conjugated secondary antibod- 
ies (Dianova, Hamburg, FRG) for another 30 rain. The secondary antibod- 
ies were usually pretreated for 5-10 rain with 5 % low fat milk powder and 
were centrifuged for 5 rain. After three more 5-min washes with PBS, cells 
were dehydrated in ethanol, dried, and embedded in Elvanol. Fluorescence 
was  detected either with  a  conventional fluorescence microscope (Ax- 
iopbot; Carl Zeiss, Oberkochen, FRG) or a confocal laser scan microscope 
(LSM 310;  Carl Zeiss) operating with a helium-neon laser at 543 nm and 
an argon ion laser at 488 rim. 
Routine electron microscopy was as described (8, 9). FOr immtmoelec- 
tron microscopy, several fixation procedures were tested. Best results were 
obtained when cells grown to near confluency on glass coverslips were 
washed three times with 37 *C warm PBS and fixed in freshly prepared 2.5 % 
or  3%  formaldehyde in  PBS  for  30  min.  Free  aldehyde groups  were 
quenched by incubation in 50 mM Nt-hCI in PBS for 2  ×  5 min. Cells 
were lysed by a subsequent 10-rain  treatment with either 0.1% saponin in 
PBS or 0.05 % digitonin in PBS. Incubation with the primary antibodies was 
for 30-60 rain. After three washes with PBS, specimens were exposed for 
2-4 h to secondary goat antibodies that had been coupled to gold particles 
(Amersham International). Cells were again washed three times with PBS 
and fixed for 20 min with 2.5 % glutaraldehyde in 50 mM sodium cacodylate 
buffer (pH 7.4) containing 50 mM KC1 and 2.5 mM MgCl2. After several 
washes in 50 mM sodium cacodylate buffer (pH 7.4),  cells were postfixed 
with 2 % OsO+ in cold buffer for 2 h, washed, dehydrated, fiat-embedded 
in Epon, and sectioned as described (cf. 8, 9).  In some experiments, the 
immunosignal was enhanced by silver amplification (Aurion; Bio Trend, 
K/~ln, FRG). 
SubceUular Fractionation 
Cells were washed with ice-cold PBS and lysed in cold (4"C) hypotonic 
buffer containing  10  mM triethanolamine-acetic acid  (pH  7.4),  1  mM 
EGTA, 1 mM EDTA, 0.1 mM DTT, and 0.2 mM phenylmethylsulfonyl  fluo- 
ride.  The  material  was  then homogenized either  in  a  Potter-Elvejhem 
homogenizer by 25 up and down strokes or a tight-fitting Dounce homoge- 
nizer, and was subjected to centrifugation at 800 g for 5 rain. The resulting 
supematants (S1) were loaded on linear sucrose gradients that were centri- 
fuged for 160 rain at 270,000 g in a rotor (SW40 Ti; Beckman Instruments, 
Inc., Palo Alto, CA). Fractions were collected while recording the OD at 
280 um with a flow-through photometer, and the sucrose concentration of 
each fraction was determined with an Abb¢ refractometer. Alternatively, S1 
supernatants were loaded on linear glycerol gradients (5-25%) with a su- 
crose cushion (50%) at the bottom, which were centrifuged for 60 rain at 
39,000 rpm in an SW40 rotor before collection of fractions. Aliquots were 
further analyzed either by the semiquantitative dot blot assay described by 
Wiedenmann et al.  (55)  or by an ELISA. For the ELISA,  10-/~1 aliquots 
were diluted with 90/~1  PBS and pipetted into wells of a 96-well culture 
dish. After incubation under shaking for 1 h at room temperature or over- 
night at 4°C, the solution was removed, and the surface of the wells was 
blocked with 0.2% (wt/vol) BSA in PBS for 1 h. Bound proteins were re- 
acted with synaptophysin antibodies (mAb SY38 or from rabbit sera) for 
1 h, and the wells were washed several times with 0.05%  (wt/vol) Tween 
20 in PBS, followed by incubation with HRP-conjugated goat anti-mouse 
antibodies (Promega Biotec, Madison, WI) for 1 h. After several washes, 
HRP was detected with the chromogen 2,2'-azinobis(3-ethylbenzthiazoline- 
sulfonic acid) (AffiX; 50/d/well of 1%  [wt/vol] ABTS in reaction buffer 
[Boehringer Mannheim]), the reaction was stopped with 20/~l acetic acid, 
and absorbance was determined with a multichannel photometer at 405 nm. 
For direct immunoblot detection, proteins were precipitated from fractions 
by addition of 100%  "IC.A to a final concentration of 15% and incubation 
at 4"C  for  1-16 h.  The precipitates were pelleted by centrifugation at 
14,000 g for 10 rain, washed with 90% acetone, 100% acetone, and dried. 
Resohibilization of the protein in buffer, separation by SDS-PAGE, immu- 
noblotting, and detection of synaptophysin were done using standard proce- 
dures (cf. 26). 
In some instances, synaptophysin-containing vesicles were further en- 
riched from SI sucrose gradient fractions or glycerol gradient fractions by 
immunoisolation (26). To this end, magnetic particles coated with sheep 
anti-mouse  IgG1  (Dyna-Beads  M-280;  Dynal,  Hamburg,  FRG)  were 
reacted with purified mAb SY38 (10/+g of HPLC-purified antibody for 100 
/~1 of tightly packed beads) in blocking solution (PBS containing 10 mM 
EGTA, 0.1% BSA, 10 mg/ml phospbatidylcholine [Sigma]) for 20 min. Al- 
ternatively, in immunoisolation experiments using metabolically labeled 
cells, magnetic beads were first incubated at room temperature for 1 h with 
blocking solution supplemented with $1 supernatants from cells that do not 
express synaptophysin, and subsequently reacted with SY38 hybridoma su- 
pernatant in blocking solution for 1 h. After several washes with blocking 
solution, beads were added to selected cellular fractions and were incubated 
at room temperature between 20 rain and 1 h. Several washes with PBS con- 
taining 10 mM EGTA, and for the most stringent washing step, 1 M KC1, 
followed (see also 26). Immunoisolated material was either pelleted by cen- 
trifugation for 2 rain at 13,000 g and solubilized in SDS-PAGE buffer for 
subsequent immunoblot analysis and autoradiograpby, or it was centrifuged 
for  5  rain  at  800  g,  followed by  fixation  in  buffer containing  2.5% 
glutaraldehyde (see above), treatment with buffered 2%  OsO+,  dehydra- 
tion, embedding in Epon, ultrathin sectioning, and visualization under a 
Siemens 101 electron microscope (Berlin, FRG). 
Immunoprecipitation from SI (800 g supernatant of lysed and homoge- 
nized cells) was done with Eupergit C1Z beads (Rthm, Weiterstadt, FRG), 
to which rabbit or guinea pig antibodies against synaptophysin bad been 
coupled (for methodological details see 10). 
Endoglycosidase Treatment 
In some instances, immunopreeipitated synaptophysin was treated with ei- 
ther endoglycosidase H (Boehringar Mannheim) after solubilization (6 rain 
at 95"C) in 0.66% SDS, 33 mM sodiumphosphate (pH 5.4) for 20 h at 37"C, 
or with endoglycosidase F  (Bcehringer Mannheim) after solubilization (6 
min at 95"C) in 0.1 M sodium phosphate, pH 8.6, 1.2% NP-40, 0.2% SDS, 
10 mM EDTA, 1 mM PMSF, 140 mM/3-mercaptoethanol, and subsequent 
dilution with H20 (1:3) for 20 h at 37°C. 
Results 
Separation of Synaptophysin-containing Vesicles  from 
Other Vesicles 
We have previously described sublines of stably transfected 
human PLC cells that constitutively express the transfected 
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gene product in non-NE cells in greater detail, we tested a 
variety of gene constructs and selection protocols.  Clone 
PLC-6S4, which was selected for puromycin resistance (4 
#g/ml)  after  transfection with  pSR  1°  (see  Materials  and 
Methods), was used for most of the experiments described 
here, as it showed the highest level of expression determined 
by Northern blot hybridization and immunoblot quantita- 
tion. The resulting synaptophysin steady-state level was ap- 
proximately one fifth of that determined in our cultures of 
PC12 cells (9). 
In the PLC-6S4 cells, as well as in the other transfected 
cell lines examined, the vast majority of the synaptophysin 
was in an endoglycosidase H-resistant form (Fig.  1), and it 
appeared mostly in the multipunctate pattern of scattered 
vesicles (cf. 26). Under normal steady-state conditions, we 
did not detect appreciable amounts of immature, i.e., en- 
doglycosidase H-sensitive synaptophysin, and we also did 
not see any synaptophysin in the ER. The half life of the ma- 
ture synaptophysin in PLC-6S4 cells under our growth con- 
ditions exceeded 12 h, as determined by pulse chase experi- 
ments (not shown). 
Fractionation of the total cellular vesicles by glycerol gra- 
dient centrifugation, followed by ELISA with synaptophysin 
mAb SY38 (Fig. 2 A), showed that synaptophysin was con- 
tained in a major vesicle type with a distinct sedimentation 
characteristic but it appeared over a range of fractions, show- 
ing some enrichment in a "light peak" fraction (Fig. 2 A, 
fractions 6-12) and at the density cushion. When these frac- 
tions  were  further examined by  immunoisolation experi- 
ments using mAb SY38, it was found that synaptophysin- 
containing vesicle fractions also contained the transferrin 
receptor as a marker for endocytosis, although in variable 
amounts (Fig. 2, B and B'). 
To  examine the  possible  inclusion of synaptophysin in 
vesicles of the constitutive secretory pathway (el 22, 23, 38) 
of PLC cells, we compared its distribution with that of the 
hepatitis B surface antigen (HBs), a characteristic integral 
membrane protein of secretory vesicles of this cell line (30). 
Using sucrose gradient centrifugation (Fig. 2  C), vesicles 
containing synaptophysin could be clearly separated from 
Figure  1.  Autoradiograph  of 
SDS-PAGE (15 %) showing  radio- 
actively  labeled  synaptophysin 
that was immunoprecipitated  from 
human hepatoma PLC-6S4 cells 
with rabbit antibodies  to synapto- 
physin and treated for 20  h  at 
37°C with 0.2 U endoglycosidase 
F  (lane 2,  untreated control in 
lane  1)  or  endoglycosidase H 
(lane 4, untreated control in lane 
3). Cell proteins were metaboli- 
cally labeled  by overnight  incuba- 
tion of 'o106 cells with 150 #Ci 
[35S]methionine (cf. 26). Bars on the left margin denote the rela- 
tive positions of coelectrophoresed  reference  proteins (top-bottom: 
BSA, Mr "067,000; ovalbumin, Mr  ,045,000; glyceraldehyde-2- 
phosphate dehydrogenase, Mr ,036,000; carbonic anhydrase, Mr 
,'o29,000; trypsinogen, M~ ,024,000).  The position of the  gly- 
cosylated form of synaptophysin  is indicated by an arrowhead,  that 
of the aglycon obtained by endoglycosidase  F by a dot. 
vesicles carrying HBs, showing that the constitutive pathway 
secretory vesicles differ  drastically in size and sedimentation 
behavior from the majority of the synaptophysin vesicles. 
This observed steady state distribution does not, of course, 
rule out the possibility that some synaptophysin molecules 
exist as transient passengers in constitutive pathway vesicles. 
Several studies have shown that in NE cells, as well as in 
transfected non-NE cells, synaptophysin reaches the plasma 
membrane, where it can be directly visualized (26) and bio- 
chemically labeled, followed by clustering and endocytosis 
(e.g.,  2,  3,  19,  26,  28,  38).  Using the fluid-phase marker 
HRP, we have previously shown in PLC cells that only a sub- 
fraction of the HRP-labeled vesicles was also positive for 
synaptophysin (26).  This  was  also  found throughout the 
present study, and it was corroborated by biochemical ex- 
periments.  When,  for  example,  PLC-6S4  cells  were  in- 
cubated with HRP for <2 h, following the endocytosis pro- 
tocol described by Johnston et al. (19) for CHO cells, and 
vesicles were fractionated by sucrose gradient centrifugation 
(Fig. 2 D), the majority of HRP was not detected in fractions 
containing  synaptophysin  (for  a  minor  synaptophysin- 
containing fraction see Fig. 2 D, fraction 11). HRP was prac- 
tically absent from the fractions containing the small synap- 
tophysin-rich vesicles  (Fig.  2  D,  fractions  3-6).  Similar 
results were obtained after shorter incubation times (cf. 26 
and data not shown). 
When  we  labeled the  surface-bound TFR of PLC-6S4 
cells, allowed for endocytosis, and analyzed the distribution 
of labeled vesicles, the low resolution power of our sucrose 
gradient analyses did not allow the separation of TFR and 
synaptophysin vesicles under the conditions chosen (Fig. 2 
D).  Subsequent immunoisolation with synaptophysin anti- 
bodies, however,  resulted in the enrichment of vesicles that 
were rich in synaptophysin, but did not contain amounts of 
TFR detectable under these conditions (Fig.  2 E, lanes 3 
and 3'). 
Further analysis of the immunoisolates by electron mi- 
croscopy showed that the bead-attached, synaptophysin-rich 
vesicles were mostly small (<100  nm diameter),  with an 
electron-translucent interior (Fig. 3), similar to those detect- 
able in situ (see below). These observations indicated that a 
sizeable portion of the TFR and the synaptophysin is con- 
tained in different vesicles and that a subtype of synaptophy- 
sin-rich SET vesicles contains very little, if any TFR. 
Light and Electron Microscopic Identification of 
Synaptophysin-containing  Vesicles 
To compare directly the overall distribution of synaptophysin 
with that of TFR-containing vesicles, we performed double- 
label immunofluorescence microscopy. 
Drastic differences in the distribution of the membrane 
proteins studied were observed (Figs. 4, a  and a', and 5, a 
and a). Most of the TFR immunoreactivity, detected either 
by mAb B3/25 or mAb OKTg, was seen as a coarsely granu- 
lar staining, often showing enrichment in a juxtanuclear ag- 
gregate,  whereas  synaptophysin appeared  in  the  typical 
finely punctate pattern throughout most of the cytoplasm. 
Small granular structures coincidentally positive for both 
TFR and synaptophysin were also repeatedly noticed (for a 
detailed comparison see inserts in Fig. 5, a  and b). 
A similar differential localization was seen when the dis- 
tribution of synaptophysin was compared with that of the 
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from PLC-6S4 cells by centrifugation and immunoisolation tech- 
niques. (A) Quantitation of relative synaptophysin concentration in 
glycerol  gradient fractions. 500 #1 of a postnuclear (1,000 g) super- 
natant  (2  mg  protein/1  ml)  were  loaded onto  a  linear  5-25% 
glycerol gradient with a 50% sucrose cushion at the bottom. After 
centrifugation at 39,000 rpm for 60 rain in a SW40 Ti rotor (Beck- 
man) 400 #1 fractions were collected from top (fraction 1) to bot- 
tom.  The  relative synaptophysin concentration was  determined 
with an ELISA (E, absorbance at 405 nm in OD units is given on 
the ordinate).  (B) Immunoblots of immunoisolates from vesicle 
fractions of postnuclear supernatant.  Polypeptides contained  in 
equal volumes of immunoisolates were separated by SDS-PAGE 
(12%), transferred to nitrocellulose filters, and reacted with beads 
coated with mAb SY38,  using the enhanced chemiluminescence 
system (Amersham) for detection (see Materials and Methods). As 
positive control, lane I  contains total postnuclear supernatant (20 
#g). For negative controls, magnetic beads coated only with sec- 
ondary antibodies were  incubated with postnuclear supernatant 
(lane 2), pooled glycerol gradient fractions 6-12 (lane 3) or 25-30 
(lane  4).  Synaptophysin-containing vesicles were  isolated with 
mAb SY38 from postnuclear supernatant (lane 5), in comparison 
with pooled glycerol  gradient fractions 6-12 (lane 6) or 25-30 (lane 
7). The relative position of molecular mass standards are indicated 
by dots (from top to bottom:/~-galactosidase, Mr 'o116,000;  phos- 
phorylase b,  Mr  ,o97,400;  BSA,  Mr  ~67,000;  ovalbumin,  Mr 
,o45,000). The arrowhead denotes the position of the immunoglob- 
ulin heavy chain detected by the secondary antibody. Note synap- 
tophysin reaction in lanes I  and 5-7.  (B') Immunoblot of the same 
fractions as in B, but reacted with mAb OKT9 against human TFR. 
Same  experimental  conditions  and  denotations  as  in  B.  Note 
markedly positive reaction in lanes 1', 5', and 7'. (C) Quantitation 
of immune reactions of blotted protein fractions (fraction numbers) 
obtained after velocity gradient centrifugation (5-30%  linear su- 
crose gradient; 260,000 g  for 160 min) of overlayed postnuclear 
(1,000  g)  supernatants.  Protein fractions collected from bottom 
(left) to top (right) were either reacted with mAb SY38 against syn- 
aptophysin (asterisks)  or  with  antibodies against the bulk  flow 
marker HBs (circles). Ordinate presents mean values of extinction 
at 490  tim from seven independent experiments. Synaptophysin 
peak fractions 3 and 4 were 20% and 19% with respect to sucrose 
concentration, whereas the HBs-containing peak fraction 6  con- 
tained  16%  sucrose.  (D)  Graphs  showing  the  distribution of 
synaptophysin-containing  vesicles in comparison to those contain- 
ing either TFR (open squares) or HRP (dotted circles) in sucrose 
gradient fractions from PLC-6S4 cells (same procedures as in C). 
Synaptophysin immunoreactivity (asterisks)  was  determined by 
quantitation of absorption at 490  nm in a dot blot immunoassay 
using mAb SY38. For detection of TFR, cells had been incubated 
with TFR mAb B3/25  (10 #g/rnl), together with secondary 3sS- 
labeled sheep anti-mouse Ig (20 #Ci/10-cm culture dish) for 1 h 
before harvesting. Radioactivity was measured in 50-#1 aliquots of 
sucrose gradient fractions by liquid scintillation counting. For up- 
take of HRP, cells were incubated for 2 h with HRP (10 mg/ml) and 
peroxidase activity was determined in 0.2-ml aliquots of sucrose 
gradient fractions by adsorption at 450 nm 30 min after reaction 
of o-dianisidine in the presence of H202.  Similar results were ob- 
tained with TFR mAb OKT9. (E) Immunoblot using rabbit synap- 
tophysin antibodies and the alkaline phosphatase detection system 
(a)  and corresponding autoradiograph (b) of polypeptides sepa- 
rated by SDS-PAGE (15 %) from ceils labeled with TFR antibodies 
(see D), demonstrating the segregation of synaptophysin-  and TFR- 
containing vesicles. 5 % of postnuclear supernatant was loaded in 
lanes I  and 1', 1% of pooled sucrose fractions 4-6 were loaded in 
lanes 2 and 2'. Synaptophysin-containing  vesicles were further en- 
riched from 50% of this pool by immunoisolation using magnetic 
beads coated with mAb SY38 via secondary antibodies (lanes 3 and 
3'; see Materials and Methods). As a negative control, the rest of 
the sucrose gradient pool fraction was  incubated with magnetic 
beads coated only with secondary antibodies (lanes 4 and 4'). The relative position and relative molecular mass values (in kilodaltons) 
of coelectrophoresed molecular mass references (cf. Fig.  1) are indicated at the left margin. Note the enrichment of synaptophysin and 
concomitant reduction of the 3sS-labeled heavy and light chains of the secondary antibody associated and endocytosed with the TFR in 
the immunoisolated vesicles. Note that the strong synaptophysin signal in lane 3 does not correspond to a TFR reaction (lane 3'). Only 
after extended exposure a very weak signal could be detected in lane 3' (not shown). Figure 3. Electron micrographs of immunoisolated vesicles from PLC cells transfected with the synaptophysin gene construct pSR  7 (cf. 
26).  Synaptophysin-containing vesicles were immunoadsorbed to magnetic beads coated with mAb SY38. The micrograph in (a) shows 
one such magnetic bead (diameter ~3.2 #m) surrounded by a number of tightly attached, rather small vesicles (most diameters =  30-100 
rim).  The inset in a  depicts a tubular structure that was seen attached to another bead.  (b and c) Details of a  at higher magnification. 
(d-g) Demonstration of the abundance and size variation of SET vesicles adsorbed to other beads. Bars,  1/zm in a, 500 nm in inset of 
a  and d-g;  200 nm in b  and c. 
TFR-containing  vesicles,  visualized by bound  and endocy- 
tosed ligand at subsaturation levels (Fig. 4, b and/¢).  Using 
various drugs, including brefeldin A, that can alter the distri- 
bution of endosomal structures  and markers  (cf. 47),  such 
as  TFR,  we  did  see  some  but  by  no  means  a  complete 
colocalization of TFR and synaptophysin (Fig. 4,  c and d). 
When such colocalization experiments were performed on 
various other transiently transfected epithelial ceils, similar 
results were obtained.  As shown for the example of A-431 
cells (Fig. 4, d  and d'), a  number of "dots" were fluorescent 
for both antigens, but many others showed mutual exclusivity 
for either  synaptophysin or TFR. 
To identify and characterize the synaptophysin-containing 
structures  appearing  as  small  "fluorescent  dots"  in  im- 
munofluorescence microscopy (e.g.,  see Fig.  5  a), we per- 
formed immunoelectron microscopy on such cells using the 
same primary antibodies and secondary immunogold label- 
ing (Fig.  5  c).  The majority of the structures  decorated by 
synaptophysin  antibodies,  as  visualized  by  gold  particles, 
were  SET  vesicles  with  diameters  in  the  30-90-nm  range 
(Fig. 5 c, arrows), whereas minor proportions of somewhat 
larger vesicles were also labeled,  including  occasional  late 
endosomes appearing as multivesicular bodies (see below). 
In quantitative  evaluations  in  the  form of histograms  (not 
shown),  83%  of the  immunogold-labeled  vesicles fell into 
the diameter size classes of 60-90  nm (43%)  and <60 nm 
(40 %), i.e., the size category defined as SLMV. For compar- 
ison,  the  corresponding  figures  for  synaptophysin  anti- 
body-labeled vesicles in the "typical" NE cells of line PC12 
were 92%  (30-60  nm) and 6%  (60-90  nm). 
To visualize  directly  the  individual  vesicles of the  three 
different  kinds  (SY÷/TFR  -,  SY-/TRF +,  SY+/TFR÷),  laser 
Figure 4. Double-label immunolocalization of synaptophysin (a-d) with TFR, visualized by TFR antibodies (a', c', d') or by bound and 
endocytosed transferrin (b'), in methanol/acetone-fixed PLC-6S4 (a-c and a'-c') or A431-5S4  (d and d') cells. (a and a') Synaptophysin 
was detected with affinity-purified rabbit antibodies, TFR with murine mAb B3/25.  (b and b') Colocalization of synaptophysin (using mAb 
SY38) and transferrin using affinity-purified rabbit antibodies. Transferrin was added to cells before fixation at a concentration of 15 tzg/ml 
for 1 h. (c and c') Cells were incubated with 20 izg/rnl cycloheximide for 4 h and with 5/zg/ml brefeldin A and 10 ttg/ml TFR antibody 
B3/25 for 3 h before fixation.  Endocytosed TFR antibody was detected only with labeled secondary antibody, whereas affinity-purified 
rabbit antibodies were used for detection of synaptophysin. (d and d') Colocalization of synaptophysin and TFR in the synaptophysin- 
producing selected A-431 cell subline 5S4, using the same reagents as in (a and a'). Arrows in d point to a series of fluorescent dots not 
seen in d', whereas the circle in d marks one of the dots not present in d. Note the differences in overall distribution between both vesicle 
populations in all pairs of micrographs. Bars, 20/zm. 
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ization of synaptophysin (green) and the TFR (red) in PLC-6S4 
cells. Methanol/acetone-fixed cells were incubated simultaneously 
with  affinity-purified  synaptophysin  antibodies  from  rabbit  and 
mAb B3/25  against TFR,  followed by reaction with preadsorbed 
secondary fluorescein-conjugated goat anti-rabbit IgG antibodies 
and Texas red-coupled goat anti-mouse IgG antibodies.  Fluores- 
cence was recorded by simultaneous scanning in the same focal 
plane by a  helium-neon  and  argon  laser.  Note  the  presence  of 
orange/red  and  green punctate  staining  in addition to yellowish 
dots, indicating  separate (orange~red,  and green) localization or co- 
distribution  (yellow;  the  number  of codistributive  sites  may be 
somewhat overestimated because of the limitations of resolution of 
closely adjacent vesicles). Bar, 5 tzm. 
scan microscopy and digital  imaging procedures  were used 
(Fig. 6). Optimal resolution was usually obtained in the pe- 
ripheral  cytoplasm,  where  the cells  were flattened  out.  In 
general,  synaptophysin immunoreactivity (green color) was 
more  prominent  than  TFR  immunofluorescence  (orange/ 
red).  In addition,  yellow  fluorescent  "dots" were  regularly 
seen,  representing  vesicles containing  both antigens. 
The numerous sites of differential synaptophysin and TFR 
signals in punctate immunofluorescent  signals and electron 
microscopic  vesicles,  respectively,  show  that  both  mem- 
brane proteins  can  greatly  differ  in  their  enrichment  in  a 
specific vesicle, although the presence of a few molecules in 
Figure 5. Details of immunolocalization of synaptophysin and TFR 
in PLC-6S4 cells. (a and b) Double-label immunofluorescence mi- 
croscopy of synaptophysin using afffinity-purified antibodies from 
rabbit (a), and TFR using mAb OKT9 (b) on methanol/acetone- 
fixed cells.  Note the only partially coincident, but mostly different 
distribution of both antigens.  The insets show a selected region at 
higher  magnification,  demonstrating  examples  of colocaiization 
(circles), as well as structures labeled only by synpatophysin anti- 
bodies  (a,  arrows).  (c)  Representative  immunoelectron  micro- 
graph showing  the synaptophysin-containing vesicles. Cells were 
fixed with 2.5 % formaldehyde and lysed with 0.1% saponin before 
antibody incubation. Note immunogold localization predominantly 
in small (diameter =  30-90 nm), electron-translucent vesicles (ar- 
rows). NE, nuclear,  envelope. Bar,  0.5/~m. 
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sidering the limits of detection of the specific methods. 
Immunoelectron Microscopic Comparison of 
Synaptophysin and Endocytosed TFR 
To exclude a preferential intravesicular location of the TFR 
epitope, resulting in the shielding from detectability by inac- 
cessibility, we also used a protocol in which the surface- 
bound TFR of living cells were labeled with TFR antibodies 
and then with the corresponding labeled secondary antibod- 
ies. The distribution of  the endocytosed TFR-antibody com- 
plexes was indistinguishable from that of the receptor (Figs. 
4-6; for use of  labeled primary antibody, e.g., see references 
15, 16). Fig. 7 presents the characteristic distribution of en- 
docytosed TFR  in  transfected PLC  cells,  which  clearly 
differs from that of synaptophysin (compare, e.g., Fig. 5 c). 
At early time points, immunogold particles were mostly 
detected in clathrin-coated pits or in vesicles close to the 
plasma  membrane,  including  certain  elongated  vesicles, 
which possibly correspond to tubular and "cup-shaped" early 
endosomes (15, 16, 47). TFR label could be seen in vesicles 
of different sizes and morphological appearances.  At later 
time points, gold particles were contained in small (50-150 
nm) cortical vesicles or tubular structures. Similarly sized 
and labeled vesicles were also found in the trans-Golgi net- 
work and other parts of the Golgi region (cf. 12, 18, 56). In 
addition,  TFR immunoreactivity was  found within larger 
vesicles  corresponding  to  late  endosomes  or  structures 
resembling multivesicular bodies (13, 16, 36, 47). 
In double-label immunoelectron microscopy, we exam- 
ined with particular care areas in which label for both mark- 
ers  could be  seen  in the  same  field (e.g.,  Fig.  8,  a-f). 
Analysis of sections through numerous ceils showed the si- 
multaneous  presence  of  three  major  kinds  of  labeled 
vesicles. 
(a)  Corresponding  to  the  immunofluorescence pattern 
(e.g., Figs. 4, a' and b, and 5 b), TFR antibodies reacted with 
certain vesicles of  rather variable sizes, including many large 
ones such as "multivesicular bodies; but also with smaller 
vesicles and some tubular extensions, in the absence of any 
detectable synaptophysin label. 
(b)  Conversely, a large number of smaller SET vesicles 
were only labeled by antibodies to synaptophysin, but not 
with TFR antibodies. These vesicles also differed in size, and 
we grouped them into those with larger (>90 nm) and those 
with smaller (30-90 nm) diameter. The latter category cor- 
responds to the SLMV of PC12 and other NE cells (e.g., see 
above and references 5, 9, 29, 33, 37, 38, 45, 52, 54). Occa- 
sionaUy,  we  observed  some  elongated  membrane-bound 
structures suggestive of "tubular extensions" that were also 
positive for synaptophysin (for example, see Fig. 8 a), simi- 
lar to the "cisternal"  or "tubular" structures found positive for 
synaptophysin in pancreatic islet j3 cells (37). 
(c) A subtype of variously sized vesicles was positive for 
both internalized TFR and synaptophysin antibodies on the 
cytoplasmic surface of the vesicle. 
Similar results  of immunofluorescence microscopy and 
single- or double-label  immunogold electron microscopy 
were obtained for selected subelones of transfected cells of 
the hepatoma-derived cell line SK-Hep-1 (subclone 1S4) and 
the vulvar carcinoma-derived cell line A-431 clone E3 (sub- 
clone 5S4). In all transfected cell clones, the induced expres- 
sion of  the gene encoding rat synaptophysin  and the inclusion 
of theproduct in SET was a stable feature, observed in the 
oldest PLC subline, now for >4 yr of continued cell prolifer- 
ation. 
Discussion 
Synaptophysin, a  major constituent glycoprotein of small 
(30-90 nm) electron translucent vesicles, i.e., PSV in neu- 
rons and SLMV in diverse NE cells, has become a model 
molecule for studying mechanisms of specific membrane 
protein sorting and vesicle formation. It is generally agreed 
that in the presynaptic cytoplasm of neurons synaptophysin, 
together with other PSV proteins, can go through several cy- 
cles of triggered exocytosis and endocytotic recycling, prob- 
ably via coated vesicles (cf. 14, 32, 53). Controversy, bow- 
ever, starts when it comes to the questions of  the site of initial 
assembly and sorting of synaptophysin and other vesicular 
components, and of the form and the route by which these 
vesicle proteins reach the presynaptic region (e.g., 28,  31, 
38, 46). 
Even more controversial are the discussions on the molec- 
ular principles and pathways of the formation of synaptophy- 
sin-containing vesicles in NE cells, including the PC12 cell 
line, and in non-NE ceils forced to synthesize synaptophysin 
by transfection with recombinant gene constructs (2--4, 9, 
19, 26, 28, 29, 38). We (26) and others (19, 28) have reported 
that in such transfected non-NE cells, most of the synap- 
tophysin  accumulates  in  cytoplasmic  vesicles,  including 
those of the SLMV size class. However,  comparing trans- 
fected cell cultures of fibroblastoid lines (CHO and 3T3) 
with NE cells (PC12),  Kelly and colleagues (3, 21-23,  28, 
see also 2, 5, 6) have stated that synaptophysin is sorted into 
SET vesicles of the "correct" (PSV or SLMV) size class only 
in "competent; i,e., NE cells, whereas non-NE cells would 
be unable to sort this molecule into such vesicles, resulting 
in their entrance into the lysosomal pathway and/or their un- 
sorted inclusion, together with diverse plasma membrane 
molecules in the general endosomal-plasma membrane recy- 
cling shuttle (see also 5). These authors, as well as Cameron 
et al. (2), concluded therefore that the sorting machinery for 
PSV and SLMV is only present in neurons and NE cells (for 
reviews  see 21, 22). 
In contrast, using human epithelial PLC cells, we have 
reported that most of the foreign synaptophysin molecules 
accumulate in a certain type of SET vesicle in which they 
can represent, under certain conditions, a predominant pro- 
tein (26).  Our present study in three different epithelial cell 
lines confirms and extends this observation by the demon- 
stration, with three independent methods (particle fraction- 
ation, immunoisolation, and immunolocalization), of synap- 
tophysin-containlng SET vesicles of diameters in the range 
of 30-90 nm, as it is characteristic of SLMV of typical NE 
cells (5, 9, 29, 33, 37, 45). We take this specific enrichment 
of synaptophysin in a distinct type of SET vesicle, which is 
morphologically indistinguishable from SLMV, to indicate 
the existence of a sorting mechanism functioning for a NE- 
typical molecule even in a non-NE cell. 
Our conclusion of the ability of various non-NE cells to 
direct "foreign" synaptophysin  to ST vesicles with the correct 
size for SLMV finds also support in published data, though 
not the conclusions of other authors. Careful reexamination 
of the micrographs of the groups studying fibroblastoid cells 
Leube et al. Synaptophysin  Sorting in Nonneuronendocrine  Cells  1597 Figure 7. Immunoelectron  microscopic  localization of endocytosed  TFR in PLC-6S4 cells. Iron-depleted  cells were incubated with TFR 
mAb B3/25 (10 #g/ml) and secondary antibodies coupled to 15-nm colloidal gold particles  (diluted 2:3 in DME) at 4°C for 30 min, and 
endocytotic compartments were saturated by further incubation  at 37°C for 1 h, followed by fixation in buffer containing  3 % formaldehyde: 
(see Materials and Methods). Gold particles can be seen in vesicles of widely varying sizes (arrows), some of which show tubular extensions 
(arrowheads) reminiscent  of the endosomal network. Other labeled vesicles are next to Golgi cisternae (G). In addition, many gold particles 
are contained in late endosomes and structures resembling  multivesicular  bodies (asterisks; we have not determined whether these "vesicle- Figure  8.  Double-label  immunoelectron  microscopy  of  PLC-6S4  cells,  detecting  TFR  by  mAb B3/25  and  15-nm  gold-conjugated  secondary 
antibodies  before  fixation  with  3% formaldehyde  in  PBS (as  in  Fig.  7)  and  partial  cell  lysis  with  0.1% saponin,  followed  by incubation 
with  affinity-purified  synaptophysin  antibodies  (from  rabbit)  and secondary  antibodies  coupled  to  5-nm gold  particles.  (a)  Juxtanuclear 
region  (NE, nuclear  envelope)  and  cytoplasm  (PM, plasma  membrane), showing  that  the  TFR-specific  15-nm  gold  particles  are  predomi- 
nantly  detected  in  the  lumina  of  large  vesicles,  including  those  resembling  multivesicular  bodies  (asterisks),  whereas small  gold  particles 
decorate  the  outside  of  synaptophysin-containlng  vesicles  of  larger  (90-120  nm; long  arrows)  and  smaller  (30-90 nm; some are  denoted 
by  small  arrows)  diameter.  (b)  Survey  micrograph  of  a  large  cytoplasmic  area  showing  the  abundance  of  small  (~120  ran)  vesicles  decorated 
by  5-nm  gold  particles,  i.e.,  containing  synaptophysin,  and  somewhat  larger  (90-150  nm)  vesicles  that  are  positive  for  either  synaptophysin 
(5-nm  gold;  one example is  labeled  e),  or  only  for  internalized  TFR (15-nm gold;  c),  or  for  both (for  example see  d). These  different 
types  of  vesicle  are  shown at  higher  magnification  in  c-e;  for  comparison,  an  example of  the  small  (~60 nm) vesicles  is  shown in  (f). 
Bars,  0.5/~m in  a and b; 50 nm in  c-f. 
containing vesicles" contain lysosomal activities or represent "receptosomes" sensu [36]).  M, mitochondria; IF, intermediate-sized illa- 
ments. The inset (upper left) shows the distribution of TFR in cells that were only incubated for 5 rain at 37°C before fixation. The region 
shown is in close proximity to the plasma membrane and contains gold label within early endosomes (arrows denote membrane-bound 
structures, open arrowheads denote a clathrin-coated pit budding off the plasma membrane).  V, villus. Bars, 0.5/~m, 0.2 f,m in inset. transfected to produce synaptophysin has shown that indeed 
in the synaptophysin vesicle populations described vesicles 
of the typical SLMV size category were predominant, with 
some size heterogeneity. For example, the immunoelectron 
microscopy of Feany et al. (see, e.g., Fig. 5 B in reference 
6) shows that of  eight identifiable vesicles shown to represent 
a "relatively uniform vesicle population with an 80-nm di- 
ameter; six (75%) fall into the size class of 60-rim diame- 
ter and below, whereas two were much larger, falling into the 
I>100 nm class. Correspondingly, the majority of the syn- 
aptophysin-containing  "microvesicles"  described in the CHO 
cells transfected by Johnston et al. (19) and Cameron et al. 
(2) have typical SLMV diameters of 90 um and below (see 
Figs. 5 and 9 in reference 2 and Figs. 3-5 in reference 19), 
so that the authors concluded that the synaptophysin vesi- 
cles in the transfected CHO cells are similar to the genuine 
SLMV present in NE cells, such as the PC12 line. 
However,  in  our  transfected cells,  not all  synaptophy- 
sin-containing SET vesicles are identical and not all the syn- 
aptophysin synthesized is distributed in the same way. In the 
transfected epithelial cells, we have also found, in three dif- 
ferent epithelial cell lines, that some of  the synaptopbysin  oc- 
curs in endocytotically  formed vesicles, resulting from recy- 
cling through the endosome compartment, as shown by the 
colocalization with TFR (26 and the present study). Other 
authors (3, 6, 19, 21-23,  28) have interpreted their observa- 
tions in transfected fibroblastoid cells to indicate that all syn- 
aptophysin-containing vesicles are exclusively endosomes 
and represent nonsorted admixtures with various recycling 
plasma membrane markers, such as receptors for transfendn 
and LDL. However, this generalization implicating unifor- 
mity, i.e., only one vesicle route and thus only one type of 
cytoplasmic steady state vesicle, does not seem justified. 
Our present study in epithelial cells indicates that the synap- 
tophysin-containing  vesicles are not a homogeneous popula- 
tion. Both our vesicle fractionation and immunolocalization 
results show that (a) synaptophysin occurs in different kinds 
of vesicles in the same cell, often side-by-side, including oc- 
casional multivesicular bodies; (b) a large proportion of syn- 
aptophysin is contained in SET vesicles indistinguishable 
from typical SLMV; (c)  that a  subpopulation of synapto- 
physin-rich vesicles without detectable endocytotic markers 
can be distinguished from other vesicles that lack synapto- 
physin but contain markers of the endocytic recycling path- 
way; and (d) these cells also contain, in varying proportions, 
vesicles of considerably variable sizes in which synaptophy- 
sin colocalizes with endocytotic markers such as TFR (the 
latter observation being in agreement with observations in 
other cell types [2,  3, 6,  19-23, 26, 37]). 
We do not at all exclude the possibility that the synapto- 
physin-rich, SLMV-type vesicles abundant in the transfected 
cells studied also contain a few TFR molecules, as suggested 
by Linstedt and Kelly (28) and also indicated in some of our 
immunolabeling experiments.  We  consider,  however,  the 
conclusion inescapable that the demonstrated synaptophysin 
enrichment over other molecules, TFR included, in one type 
of vesicle in the transfected epithelial cells described here 
must be the result of a positive sorting specific for synap- 
tophysin, and that these synaptophysin-rich SLMV are novel 
structures in these cells since they greatly differ from vesi- 
cles of untransfected cells. Therefore, these transfected non- 
NE epithelial cells appear to represent an essentially similar 
situation as NE cells such as those of line PC12:  a  large 
proportion of the synaptophysin appears in SLMV with lit- 
tle, if any, endosomal markers, whereas another portion ap- 
pears in vesicles of a broader size range that also contain 
these endosomal markers. Hence, sorting of the NE marker 
synaptophysin is not exclusive to NE cells, a conclusion at 
variance with those of other authors from other transfected 
nonepithelial cells (for references see above). 
Perhaps non-NE cells can differ in their potential to sort 
effectively NE-typieal proteins, and certain epithelial cells 
such as those studied by us are more competent in vesicle 
sorting of  molecules usually characteristic of NE differentia- 
tion than other kinds of non-NE cells. Clearly, glycoproteins 
of the synaptophysin family are not restricted to NE cells, 
as shown by our recent discovery that many different kinds 
of non-NE cells, epithelial ones included, contain pantophy- 
sin, a protein closely related to synaptophysin, but slightly 
smaller than it (24).  Consequently, the synaptophysin de- 
rived from the transfected gene in our experiments meets the 
similar endogenous pantophysin that may serve as a "sorting 
guide: In this connection, it should also be remembered that 
NE differentiation is within the pluripotential spectrum of 
many different epithelial "stem" cells and carcinomas, re- 
spectively,  including examples of stratified tissues, as rele- 
vant for A-431 cells, and of  simple epithelial cells, as relevant 
for PLC and SK-Hepd cells, including the differentiation of 
normal NE cells or of carcinoid tumors (for liver see, e.g., 
27, 40,  41,  49,  57).  Therefore, certain epithelium-derived 
cells may contain more or better components that help to sort 
NE membrane proteins, and only careful comparisons will 
help clarifying the importance of cell type "competence" for 
stabilizing and correctly accommodating a "foreign"  NE pro- 
tein introduced. 
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